Intracranial support catheter market seen reaching $1.8B by 2030

The global intracranial support catheter market is projected to grow from $1.18 billion in 2025 to $1.29 billion in 2026, then reach $1.8 billion by 2030, according to a new Business Research Company report. Demand is being driven by rising neurological disorders, more minimally invasive neurovascular procedures and faster adoption of advanced catheter systems.

Why it matters: - Intracranial support catheters are central to neurovascular procedures that treat stroke, aneurysms and other brain vessel conditions. - Market growth signals rising demand for specialized devices that can improve navigation, procedural safety and treatment success in complex intracranial anatomy. - The expansion also points to broader investment in stroke care infrastructure and minimally invasive neurology.

What happened: - The Business Research Company released its Intracranial Support Catheter Market Report 2026 – Market Size, Trends, And Global Forecast 2026-2035 on August 12, 2026. - The report says the market will rise from $1.18 billion in 2025 to $1.29 billion in 2026. - The report projects the market will reach $1.8 billion by 2030. - North America held the largest market share in 2025. - Asia-Pacific is projected to be the fastest-growing region during the forecast period.

The details: - The report puts 2026 growth at an 8.8% CAGR, followed by 8.7% CAGR growth through 2030. - Key growth drivers include rising prevalence of neurovascular disorders, more interventional neurology procedures, advances in catheter-based treatment methods and expansion of specialized neurology centers. - Better medical imaging and wider use of precision catheter systems also support demand. - Major trends include broader use of support catheters in neurovascular treatment, advanced catheter navigation technologies, higher volumes of stroke and aneurysm procedures, stronger emphasis on device flexibility and trackability, and improved procedural safety. - Intracranial support catheters provide stability during neurovascular interventions and help guide microcatheters and delivery devices through brain blood vessels. - The devices are used in thrombectomy and aneurysm repair. - The report links demand growth to the rising prevalence of neurological disorders and an aging population. - The UK-based Alzheimer’s Society said in May 2024 that 55 million people globally are living with dementia, and that number is expected to reach 139 million by 2050. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The 2026 report edition adds market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based dashboards, market hotspots infographics, and updated technology and future trend analysis. - The report offers a free sample and the full market report through the company’s website: free sample and full report.

Between the lines: - The forecast suggests neurointerventional care is moving toward more specialized, higher-precision tools as stroke and aneurysm treatment volumes rise. - North America’s lead reflects mature healthcare infrastructure and spending, while Asia-Pacific’s growth points to improving access and expanding neurology services. - The focus on flexibility, trackability and navigation technology shows that performance features remain a main competitive battleground for device makers.

What's next: - The market is expected to keep expanding through 2030 as minimally invasive neurointerventions gain share and hospitals invest more in stroke care. - Continued device innovation and broader adoption of precision catheter systems are likely to shape product development and purchasing decisions. - The company is directing readers to its sample report, full report and sales contacts for more information.